Nothing but negotiation

 
The Gap Partnership

Actavis to be bought by Watson

Watson Pharmaceuticals is to buy Actavis.

26 April 2012

Watson Pharmaceuticals and Actavis Group have been in business negotiations, which have resulted in them entering a definitive agreement for Actavis to be acquired by Watson.

This should result in the creation of the third-largest global generics firm in the world, with pro forma revenue anticipated to reach $8 billion (£4.95 billion) in 2012.

The value of the deal is around €4.25 billion (£3.48 billion), which will be paid upfront.

President and chief executive officer of Watson Paul Bisaro said the transaction will dramatically enhance his business' global position, as well as bring "complementary products and capabilities" to the US.

Calling the acquisition "commercially compelling", he pointed out it will double his enterprise's international access and boost its operations in emerging and established markets.

Actavis has more than 10,000 members of staff in its workforce and generated an estimated $2.5 billion in revenues over 2011.

It recently launched an online academy, which has helped at least 4,000 pharmacy workers to study.

Posted by David Gleck

Source: Watson press release, April 25th

Gap News

March 2014

The Negotiation Roadshow 2014

Generating value through creative negotiation

Read more


July 2013

Trading Global: Negotiating in the Far East

The Gap Partnership are hosting a complimentary Lunch & Learn seminar in association with UK Trade & Investment

Read more


April 2013

GroceryAid Negotiation Event Raises £26,550

The Gap Partnership, in conjunction with Asda, SC Johnson and Waitrose, host one-day negotiation workshop

Read more


February 2013

Trading Global - Negotiating in the Far East

What is the impact of cultural differences on your negotiations?

Read more


December 2012

The Gap Partnership Release New Negotiation Video

The Nothing but Negotiation video series continues with collaborative negotiation

Read more